VYNE Therapeutics
VYNE
VYNE
33 hedge funds and large institutions have $18.4M invested in VYNE Therapeutics in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
33
Holders Change
+12
Holders Change %
+57.14%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
13
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLA
26
MB, Levis & Associates
Center Valley,
Pennsylvania
| $2.43K | 1,041 | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $1.97K | 846 | +662 | +360% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1.84K | 790 | +521 | +194% |
|
29
Russell Investments Group
London,
United Kingdom
| $435 | 187 | – | – |
|
30
Wells Fargo
San Francisco,
California
| $400 | 172 | +67 | +64% |
|
31
JPMorgan Chase & Co
New York
| $341 | 146 | – | – |
|
|
SPIA
32
Steward Partners Investment Advisory
New York
| $51 | 22 | – | – |
|
|
ITIM
33
Indiana Trust & Investment Management
Mishawaka,
Indiana
| $28 | 12 | – | – |
|
34
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -127 | Closed |
|
|
CFGS
35
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|